• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics
  1. home
  1. home
  2. Bill Ackman

Bill Ackman

Page 13 of 18

Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Here’s Why Valeant May Have Accused Its Former CFO of “Improper Conduct”

By Reuters
March 22, 2016
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., speaks during their annual general meeting in Laval, Quebec
Finance

What Caused Valeant’s Epic 90% Plunge

By Stephen Gandel and Reuters
March 20, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
Finance

This Valeant Investor Is In Even Bigger Trouble than Bill Ackman

By Jen Wieczner
March 18, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Here’s Why Valeant Shares Plummeted Again

By Laura Lorenzetti
March 17, 2016
Bill Ackman Actually Just Got Some Good News About One of His Investments
Finance

Bill Ackman Actually Just Got Some Good News About One of His Investments

By Stephen Gandel and Reuters
March 17, 2016
Hedge fund manager Bill Ackman
Finance

Ackman Sells Big Mondelez Stake Amid Major Losses

By Reuters
March 16, 2016
Hedge fund manager Bill Ackman
Finance

Bill Ackman’s Pershing Protégés are Struggling Too

By Marshall Hargrave
March 16, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Leadership

Valeant to Walgreens: Hey, It’s Not Your Fault After All

By Jennifer Reingold
March 16, 2016
Senate Banking Committee Hearing with Janet Yellen
Retail

The Fed Meets and China’s Li Talks–5 Things to Know Today

By Geoffrey Smith
March 16, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
Finance

Valeant Meltdown May Leave Some Hedge Funds On Their Deathbed

By Reuters
March 16, 2016
Berkshire Hathaway Annual Meeting
Finance

Why Bill Ackman Ought to Buy Warren Buffett a Coke

By Jen Wieczner
March 15, 2016
Nearly Every Stock Bill Ackman Owns Is Down This Year
Finance

Nearly Every Stock Bill Ackman Owns Is Down This Year

By Stephen Gandel
March 15, 2016
Key Speakers At The 2015 Milken Conference
Finance

Herbalife’s CEO Needs More Security Than Donald Trump

By Jen Wieczner
March 15, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
Finance

Bill Ackman Is Running Out of Options with Valeant

By Stephen Gandel
March 15, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Valeant Shareholders Push for More Details About CEO’s Illness

By Reuters
March 14, 2016

Most Popular

  • Success
    Zoom’s CEO agrees with Bill Gates, Jensen Huang, and Jamie Dimon: A 3-day workweek is coming soon thanks to AI
    By Emma Burleigh
  • Personal Finance
    Milestones like marriage and parenthood are so delayed for millennials and Gen Z many of them are skipping out on life...
    By Sydney Lake
  • Success
    Meet a 23-year-old electrician who was a 'good student' but skipped college to join Gen Z's blue-collar revolution. He...
    By Nick Lichtenberg
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.